drug company funding for drug trials is leading to biased findings and inappropriate prescribing
July 2004
There's growing concern that drug company funding for drug trials is leading to biased findings and inappropriate prescribing.
In May we told you how physicians select one drug over another based on the way study results are presented.
Now the American Medical Association just launched a campaign aimed at reducing "publication bias" in medical journals.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive